NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Liabilities from Discontinued Operations (2010 - 2023)

NextPlat's (NXPL) quarterly Liabilities from Discontinued Operations came in at $112397.0 in Q1 2023, little changed year-over-year from $112397.0 in Q1 2022, and little changed quarter-over-quarter from $112000.0 in Q4 2022.

Analysis

NextPlat (NXPL) Liabilities from Discontinued Operations (2010 - 2023) Analysis & Trends

NextPlat (NXPL) has reported Liabilities from Discontinued Operations for 14 consecutive years, with $112397.0 the latest figure, recorded in Q1 2023.

  • On a quarterly basis, Liabilities from Discontinued Operations changed 0.0% year-over-year to $112397.0 in Q1 2023; TTM through Mar 2023 was $112397.0, a 0.0% change from a year earlier, with the FY2022 full-year figure at $112000.0, changed 0.35% from the prior year.
  • Liabilities from Discontinued Operations was $112397.0 for Q1 2023 at NextPlat, roughly flat from $112000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at $112397.0 in Q1 2019 and troughed at $112000.0 in Q4 2022.
  • A 5-year average of $112373.6 and a median of $112397.0 in 2019 frame the typical range for Liabilities from Discontinued Operations.
  • Across the five-year window, Liabilities from Discontinued Operations changed 0.0% in 2019 and decreased 0.35% in 2022, its largest moves.
  • Over 5 years, Liabilities from Discontinued Operations stood at $112397.0 in 2019, then changed by 0.0% to $112397.0 in 2020, then changed by 0.0% to $112397.0 in 2021, then dropped by 0.35% to $112000.0 in 2022, then rose by 0.35% to $112397.0 in 2023.
  • The last three Liabilities from Discontinued Operations figures came in at $112397.0 (Q1 2023), $112000.0 (Q4 2022), and $112397.0 (Q3 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 112,397.00
Dec 31, 2022 112,000.00
Sep 30, 2022 112,397.00
Jun 30, 2022 112,397.00
Mar 31, 2022 112,397.00
Dec 31, 2021 112,397.00
Sep 30, 2021 112,397.00
Jun 30, 2021 112,397.00
Mar 31, 2021 112,397.00
Dec 31, 2020 112,397.00
Sep 30, 2020 112,397.00
Jun 30, 2020 112,397.00
Mar 31, 2020 112,397.00
Dec 31, 2019 112,397.00
Sep 30, 2019 112,397.00
Jun 30, 2019 112,397.00
Mar 31, 2019 112,397.00
Dec 31, 2018 112,397.00
Sep 30, 2018 112,397.00
Jun 30, 2018 112,397.00